Clinical Trial

Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis

Study acronym: VAMOS-MS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to establish differences in the primary outcome of walking dysfunction using the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) and to establish differences in the secondary outcome of HRQoL using the 29-Item Multiple Sclerosis Walking Scale (MSWS-29) between the exercise training intervention condition and the waitlist control condition following the 16-week intervention period.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-07
Trial Details
NCT Number NCT07606742
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Institutes of Health (NIH)
Conditions Multiple Sclerosis
Enrollment 66 participants
Start Date 2026-09-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06